Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin α(v)β(3) and the MC1 Receptor—Suitable for the Specific Visualization of Melanomas?

Combining two peptides addressing two different receptors to a heterobivalent peptidic ligand (HBPL) is thought to enable an improved tumor-targeting sensitivity and thus tumor visualization, compared to monovalent peptide ligands. In the case of melanoma, the Melanocortin-1 receptor (MC1R), which i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xia, Hübner, Ralph, von Kiedrowski, Valeska, Fricker, Gert, Schirrmacher, Ralf, Wängler, Carmen, Wängler, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228600/
https://www.ncbi.nlm.nih.gov/pubmed/34200477
http://dx.doi.org/10.3390/ph14060547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228600/
https://www.ncbi.nlm.nih.gov/pubmed/34200477
http://dx.doi.org/10.3390/ph14060547

Ejemplares similares